NeuPath Health Inc. filed its Annual on Mar 30, 2023 for the period ending Dec 31, 2022. In this report its auditor, Ernst & Young LLP, gave an unqualified opinion expressing doubt that the company can continue as a going concern.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.17 CAD | 0.00% | 0.00% | -8.11% |
Mar. 15 | NeuPath Health Narrows Q4 Loss, Revenue Rises | MT |
Mar. 15 | NeuPath Health Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-8.11% | 7.01M | |
-29.31% | 70.3B | |
+2.04% | 27.46B | |
-6.51% | 17.8B | |
+2.32% | 17.46B | |
+2.13% | 15.46B | |
+7.16% | 13.49B | |
+10.80% | 13.06B | |
+71.66% | 12.96B | |
+73.85% | 12.56B |
- Stock Market
- Equities
- NPTH Stock
- News NeuPath Health Inc.
- NeuPath Health Inc. Auditor Raises 'Going Concern' Doubt